Concepedia

Jacobus A. Burgers

JA

Statistics

Publications

34

Citations

2K

H-Index

24

Active since

2002

Affiliations

The Netherlands Cancer Institute(Current)

Oncode Institute

Amsterdam UMC Location University of Amsterdam

Erasmus MC Cancer Institute

Utrecht University

Jacobus A. Burgers is an author at The Netherlands Cancer Institute specializing in medicine, radiation oncology, and oncology.

Top concepts

Publications per year

2002–2023

34

Publications

34

Five-Year Survival Outcomes With Nivolumab Plus Ipilimumab Versus Chemotherapy as First-Line Treatment for Metastatic Non–Small-Cell Lung Cancer in CheckMate 227

Julie R. Brahmer, Jong-Seok Lee, Tudor–Eliade Ciuleanu et al. · Journal of Clinical Oncology · 2022 · 345 citations · Full text

First-Line Nivolumab Plus Ipilimumab in Advanced NSCLC: 4-Year Outcomes From the Randomized, Open-Label, Phase 3 CheckMate 227 Part 1 Trial

Luis Paz‐Ares, Suresh S. Ramalingam, Tudor–Eliade Ciuleanu et al. · Journal of Thoracic Oncology · 2021 · 318 citations · Full text

Thalidomide versus active supportive care for maintenance in patients with malignant mesothelioma after first-line chemotherapy (NVALT 5): an open-label, multicentre, randomised phase 3 study

Wieneke A. Buikhuisen, Jacobus A. Burgers, Andrew Vincent et al. · The Lancet Oncology · 2013 · 97 citations

, , +6

Tumor Response and Toxicity of Neoadjuvant Erlotinib in Patients With Early-Stage Non–Small-Cell Lung Cancer

Eva E. Schaake, Ingrid Kappers, Henk Codrington et al. · Journal of Clinical Oncology · 2012 · 93 citations · Full text

Malignant mesothelioma after radiation treatment for Hodgkin lymphoma

Marie L. De Bruin, Jacobus A. Burgers, Paul Baas et al. · Blood · 2009 · 84 citations · Full text

Rows per page

1–5 of 34